Alcohol use disorder (AUD) is notoriously difficult to treat, but a new therapeutic option may be on the horizon. Ondansetron, a competitive serotonin type 3 receptor antagonist currently used to prevent nausea and vomiting in patients undergoing chemotherapy or radiotherapy, is now being studied in a formulation known as AD04 for its potential to reduce … Continue reading Pharmacogenetic Approach to Treating Alcohol Use Disorder